PA Capital’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | $576K | Sell |
77,727
-27,199
| -26% | -$202K | 0.4% | 93 |
|
2020
Q2 | $438K | Sell |
104,926
-32,304
| -24% | -$135K | 0.32% | 105 |
|
2020
Q1 | $339K | Buy |
137,230
+48,916
| +55% | +$121K | 0.3% | 111 |
|
2019
Q4 | $513K | Buy |
88,314
+39,812
| +82% | +$231K | 0.45% | 83 |
|
2019
Q3 | $256K | Buy |
48,502
+8,232
| +20% | +$43.5K | 0.25% | 99 |
|
2019
Q2 | $242K | Buy |
40,270
+7,211
| +22% | +$43.3K | 0.22% | 90 |
|
2019
Q1 | $299K | Buy |
33,059
+11,020
| +50% | +$99.7K | 0.27% | 89 |
|
2018
Q4 | $183K | Buy |
+22,039
| New | +$183K | 0.19% | 95 |
|